{"id":2513,"date":"2015-02-18T23:03:20","date_gmt":"2015-02-18T23:03:20","guid":{"rendered":"http:\/\/rttheme19-rtthemes-com.rtthemes.com\/2015\/02\/19\/standard-post-2\/"},"modified":"2025-01-15T07:58:11","modified_gmt":"2025-01-15T07:58:11","slug":"standard-post-2","status":"publish","type":"post","link":"https:\/\/test.wbx.com.tr\/index.php\/2015\/02\/18\/standard-post-2\/","title":{"rendered":"ULTRAFORMER MPT – MAKALE 1"},"content":{"rendered":"

Y\u00fcksek Yo\u011funluklu Odaklanm\u0131\u015f Ultrason (HIFU) ile \u0130stenmeyen Submental Ya\u011f\u0131n Azalt\u0131lmas\u0131nda Etki ve G\u00fcvenlik<\/h3>\n

ARKA PLAN: <\/strong>“\u00c7ift \u00e7ene”(g\u0131d\u0131) t\u0131bbi olarak submental ya\u011f, g\u00fcn\u00fcm\u00fcz\u00fcn g\u00fczellik standartlar\u0131nda istenmeyen bir g\u00f6r\u00fcnt\u00fc haline gelmi\u015ftir. Bu durum ya\u015flanma ve obezite g\u00f6r\u00fcn\u00fcm\u00fc verir. Y\u00fcksek yo\u011funluklu odaklanm\u0131\u015f ultrason (HIFU), submental hacmi azaltman\u0131n olduk\u00e7a g\u00fcvenli bir yolu olarak kabul edilmektedir.<\/p>\n

AMA\u00c7: <\/strong>Bu \u00e7al\u0131\u015fman\u0131n amac\u0131, submental ya\u011f azalt\u0131m\u0131nda HIFU\u2019nun etkisini g\u00fcvenli bir \u015fekilde de\u011ferlendirmektir.<\/p>\n

Y\u00d6NTEM <\/strong>25-60 ya\u015f aral\u0131\u011f\u0131nda 30 hasta (20 kad\u0131n, 10 erkek) 4 haftal\u0131k takip program\u0131na kat\u0131ld\u0131 (n=30). Y\u00fcksek yo\u011funluklu odaklanm\u0131\u015f ultrason tedavisi, MP modunda 4,5 mm ve 6,0 mm derinlikte iki farkl\u0131 kartu\u015f kullan\u0131larak submental ya\u011f \u00fczerine uyguland\u0131. Tedavi etkilerini Vectra (hacim \u00f6l\u00e7\u00fcm\u00fcnde art\u0131\u015f), point 4’e (0~4) dayal\u0131 CR-SMFRS (Klinik Raporu-Submental ya\u011f derecelendirme \u00f6l\u00e7e\u011fi), point 3’e (0~3) dayal\u0131 SSRS (Ki\u015finin Kendi Kendini Derecelendirme \u00d6l\u00e7e\u011fi), kilo ve foto\u011fraf kullanarak de\u011ferlendirdik. \u0130stenmeyen olay anketler kullan\u0131larak yap\u0131ld\u0131.<\/p>\n

BULGULAR<\/strong> 4 hafta s\u00fcren \u00e7al\u0131\u015fmaya toplam 30 hasta kat\u0131l\u0131m g\u00f6sterdi. Tedavi g\u00f6ren hastalar\u0131n g\u00f6r\u00fcn\u00fc\u015flerinden memnuniyet oran\u0131 y\u00fcksek bulunmu\u015f ve submental ya\u011fda \u00f6nemli bir azalma kaydedilmi\u015ftir. CR-SMFRS sonu\u00e7lar\u0131na g\u00f6re, tedavi sonras\u0131 10 hafif hasta, 10 orta hasta, 8 ciddi hasta, 2 a\u015f\u0131r\u0131 ciddi hasta varken, bir tedavi seans\u0131 sonras\u0131nda bu oranlar 16 hafif, 8 orta, 5 ciddi ve 1 a\u015f\u0131r\u0131 ciddi olarak de\u011fi\u015fmi\u015ftir. \u00d6nemli iyile\u015fme kaydedildi, p<0.000005. SSRS %82 idi (\u0130yile\u015fme Seviyesi) ve ayr\u0131ca hastalar\u0131n \u00e7o\u011funda hemen iyile\u015fme g\u00f6r\u00fcld\u00fc. \u00d6nemli yan etki veya olumsuz etki bildirilmedi. Beklenen yayg\u0131n yan etkiler kaydedilmi\u015f olup, bu etkiler 2 hafta i\u00e7inde d\u00fczelmi\u015ftir.<\/p>\n

SONU\u00c7<\/strong> HIFU, submental ya\u011f azalt\u0131m\u0131nda g\u00fcvenli ve etkili bir y\u00f6ntem olarak de\u011ferlendirilmi\u015ftir.<\/p>\n

<\/h3>\n

G\u0130R\u0130\u015e<\/strong><\/p>\n

Submental b\u00f6lgede deri alt\u0131 ya\u011f birikimi, alt y\u00fcz konturunun ve mandibular hatt\u0131n kayb\u0131na yol a\u00e7abilir. Bu durum, ya\u015f ve cinsiyetten ba\u011f\u0131ms\u0131z olarak obezite ve ya\u015flanma g\u00f6r\u00fcn\u00fcm\u00fc verir ve olumsuz estetik ve psikolojik etkilere katk\u0131da bulundu\u011fu g\u00f6sterilmi\u015ftir (Kwon et al., 2021). Cerrahiden, iyile\u015fme s\u00fcrelerinden ve komplikasyonlar\u0131ndan korkan hastalar, daha az invaziv y\u00f6ntemler aramaktad\u0131r (Kamer & Minoli, 1993). Cerrahi olmayan bir teknik olarak HIFU, cerrahi y\u00fcz germeden daha az iyile\u015fme s\u00fcresi gerektirir. Son zamanlarda, non-invaziv ya\u011f azaltma i\u00e7in \u00e7e\u015fitli y\u00f6ntemler kullan\u0131lmaktad\u0131r. G\u00fcvenli ve non-invaziv yap\u0131s\u0131 nedeniyle, \u00f6zellikle submental ya\u011f\u0131n azalt\u0131lmas\u0131 da dahil olmak \u00fczere kozmetik ama\u00e7l\u0131 HIFU tedavisi d\u00fcnya \u00e7ap\u0131nda yayg\u0131n bir pop\u00fclerlik kazanm\u0131\u015ft\u0131r. HIFU’nun prensibi, hedeflenen b\u00f6lgede an\u0131nda mikrotermal lezyonlar olu\u015fturarak, koag\u00fclasyon yoluyla se\u00e7ici olarak h\u00fccre hasar\u0131 olu\u015fturmak ve hedef b\u00f6lgede hacim k\u00fc\u00e7\u00fcltmektir. Farkl\u0131 kartu\u015flar kullan\u0131larak \u00e7e\u015fitli penetrasyon derinlikleri 4.5mm, 6.0mm odak derinli\u011fi submental ya\u011f\u0131n azalt\u0131lmas\u0131na ve dokular\u0131n s\u0131k\u0131la\u015fmas\u0131na katk\u0131da bulunur (Park et al., 2015). Ayr\u0131ca 6.0mm kartu\u015f v\u00fccudun belirli bir b\u00f6l\u00fcm\u00fcndeki ya\u011f\u0131n azalt\u0131lmas\u0131n\u0131 g\u00f6sterir (Choi et al., 2016, Oni et al., 2014). Bu \u00e7al\u0131\u015fmada klinik iyile\u015fmeyi ve yan etkileri de\u011ferlendirdik.<\/p>\n

 <\/p>\n

KATILIMCILAR VE Y\u00d6NTEMLER<\/strong><\/p>\n

Bu \u00e7al\u0131\u015fmaya 30 Koreli hasta kat\u0131ld\u0131 (Tablo 1). Kat\u0131l\u0131mc\u0131lar, CR-SMFRS \u00f6l\u00e7e\u011fine g\u00f6re (0’dan 4’e kadar, yoktan a\u015f\u0131r\u0131ya) ve submental ya\u011flar\u0131na dair kendi memnuniyet d\u00fczeylerini SSRS (kat\u0131l\u0131mc\u0131n\u0131n kendi kendini de\u011ferlendirme \u00f6l\u00e7e\u011fi, 0’dan 3’e kadar) kullanarak genel de\u011fi\u015fiklikleri ve memnuniyet seviyelerini tan\u0131mlayarak \u00e7al\u0131\u015fmaya uygun bulunmu\u015ftur. Keloid skar ya da gebelik ge\u00e7mi\u015fi olan, tedavi alan\u0131nda a\u00e7\u0131k yara veya lezyonlar, cilt enfeksiyonlar\u0131, hemorajik bozukluk ve v\u00fccut BMI’si >35kg\/m2 olan hastalar de\u011ferlendirme d\u0131\u015f\u0131nda tutuldu. Ayr\u0131ca, kilo verme programlar\u0131na kat\u0131lm\u0131\u015f olan veya diyet yapmay\u0131 planlayan hastalar da de\u011ferlendirme d\u0131\u015f\u0131nda tutuldu. T\u00fcm hastalardan onam formu al\u0131nd\u0131, hastalar beklenen sonu\u00e7lar, olas\u0131 yan etkiler ve olumsuz etkiler hakk\u0131nda bilgilendirildiler. Bu \u00e7al\u0131\u015fman\u0131n protokol\u00fc Helsinki Bildirgesi (1975) y\u00f6nergelerine uyumludur. Tedavi sonras\u0131 hemen dahil olmak \u00fc<\/p>\n

zere bir ayl\u0131k takip s\u00fcresi sonun<\/p>\n

da de\u011ferlendirme ve foto\u011fraflar anketler arac\u0131l\u0131\u011f\u0131yla al\u0131nd\u0131.<\/p>\n

<\/h3>\n

\"\"<\/p>\n

\u015eekil 1. CR-SMFRS: Submental Ya\u011f Derecelendirme \u00d6l\u00e7e\u011fi<\/p>\n

\"\"<\/p>\n

Bu \u00e7al\u0131\u015fmada, MP modlu tek bir HIFU cihaz\u0131 (Ultraformer MPT: Classys, Inc., Seul, Kore) kullan\u0131lm\u0131\u015ft\u0131r. Klinik uzman, submental ya\u011fa 4,5 mm ve 6,0 mm olmak \u00fczere iki farkl\u0131 kartu\u015fla 100 ve 120 at\u0131\u015f (0,5J\/0,7J) yapm\u0131\u015ft\u0131r. T\u00fcm hastalara, 30-40 dakika s\u00fcreyle topikal anestezik krem uygulanarak tek seansl\u0131k bir tedavi uygulanm\u0131\u015ft\u0131r. Mandibular sinire zarar vermemek i\u00e7in tedavi alan\u0131nda mandibular sinir boyunca 1,0 cm’lik bir alan korunmu\u015ftur (\u015eekil 1). Ayr\u0131ca, sinerji etkisi ve s\u0131k\u0131la\u015ft\u0131rma amac\u0131yla \u00e7ene hatt\u0131nda normal modda 4,5 mm\u2019lik kartu\u015fla 30 at\u0131\u015f (0,7J) yap\u0131lm\u0131\u015ft\u0131r (\u015eekil 2). Ortalama olarak toplamda 250 at\u0131\u015f yap\u0131lm\u0131\u015ft\u0131r.<\/p>\n

\"\"\"\"<\/p>\n

\n
\n
\n
\n

\u015eekil 1<\/strong>. Sar\u0131: 6,5 mm ve Mavi: 4,5 mm kartu\u015flar, diyagrama g\u00f6re MP modunda kullan\u0131lm\u0131\u015ft\u0131r.<\/p>\n

\"\"<\/p>\n

\n
\n
\n
\n

\u015eekil 2<\/strong>. Mavi: 4,5 mm kartu\u015f, diyagrama g\u00f6re normal modda kullan\u0131lm\u0131\u015ft\u0131r.<\/p>\n<\/div>\n

 <\/p>\n

SONU\u00c7 VE KL\u0130N\u0130K ETK\u0130<\/strong><\/p>\n

Bir ayl\u0131k takipten sonra hastalar\u0131n \u00e7o\u011funlu\u011fu sonu\u00e7tan memnundu. Objektif SSRS de\u011ferlendirmesi tedavi edilen t\u00fcm hastalar\u0131n %82’si (74\/90) idi. 15 hasta belirgin iyile\u015fme (point 3) ile yan\u0131t verdi, 14 hasta hafif iyile\u015fme (point 2) ile yan\u0131t verdi ve 1 hasta (point 1) de\u011fi\u015fmeden yan\u0131t verdi. CR-SMFRS Tablo 2’de a\u015fa\u011f\u0131da de\u011ferlendirilmi\u015ftir. \u00d6nemli iyile\u015fme kaydedildi, p<0.000005. Ayr\u0131ca tedaviden sonra hemen iyile\u015fme g\u00f6r\u00fcld\u00fc.<\/p>\n<\/div>\n

\"\"<\/p>\n<\/div>\n

\"\"<\/p>\n

\"\"<\/h3>\n

\"\"<\/p>\n

\"\"<\/p>\n<\/div>\n

\"\"<\/p>\n

\"\"<\/p>\n

\"\"<\/p>\n

\"\"<\/p>\n<\/div>\n

\"\"<\/p>\n

\"\"<\/p>\n

\"\"<\/p>\n

\"\"<\/p>\n

\"\"<\/p>\n

\"\"<\/p>\n

\"\"<\/p>\n

\"\"<\/p>\n<\/div>\n

VECTRA \u00d6L\u00c7\u00dcM\u00dc<\/strong><\/p>\n

HIFU tedavisinden \u00f6nce ve sonra yap\u0131lan \u00fc\u00e7 boyutlu (3D) Vectra \u00f6l\u00e7\u00fcm\u00fcyle (Canfield Scientific, Inc) yap\u0131lan analiz.<\/p>\n

Yanda bulunan g\u00f6rsellerde, baseline g\u00f6rselinin takip ziyaretiyle kar\u015f\u0131la\u015ft\u0131r\u0131ld\u0131\u011f\u0131nda topografik de\u011fi\u015fiklikleri g\u00f6sterilmektedir. Diyagramda g\u00f6r\u00fcld\u00fc\u011f\u00fc \u00fczere, submental ya\u011fda bir azalma oldu\u011funu g\u00f6zlemlenmektedir<\/p>\n<\/div>\n

\n
\"\"

1 Ay Sonras\u0131<\/p><\/div>\n

G\u00fcvenlik Profili<\/strong>
\nTedavi s\u0131ras\u0131nda hastalar yaln\u0131zca minimum d\u00fczeyde a\u011fr\u0131 hissetmi\u015ftir. Hi\u00e7bir hasta tedavi s\u0131ras\u0131nda ek a\u011fr\u0131 kesici ila\u00e7 ya da sedasyon talep etmemi\u015ftir. 18, 15 ve 10 hastada hafif a\u011fr\u0131, eritem (k\u0131zar\u0131kl\u0131k) ve \u00f6dem gibi beklenen yan etkiler g\u00f6zlemlenmi\u015f olup, bu etkiler 3 g\u00fcn i\u00e7inde d\u00fczelmi\u015ftir. Tedavi sonras\u0131 kal\u0131c\u0131 uyu\u015fma, sinir hasar\u0131 veya yara izi gibi herhangi bir olumsuz etki g\u00f6r\u00fclmemi\u015ftir. G\u00fcvenlik profiliyle ilgili ayr\u0131nt\u0131l\u0131 bilgiler \u015eekil 1’de sunulmu\u015ftur. T\u00fcm hastalar tedavi sonras\u0131nda g\u00fcnl\u00fck aktivitelerine hemen d\u00f6nebilmi\u015ftir.<\/p>\n

 <\/p>\n<\/div>\n<\/div>\n

 <\/p>\n

\n
\n
\"\"

\u015eekil 1. Anketlere g\u00f6re: “Hangi yan etkiyi ya\u015fad\u0131n\u0131z?”<\/p><\/div>\n

SONU\u00c7<\/strong><\/p>\n

Kozmetik dermatolojide non-invaziv ve daha az zaman alan prosed\u00fcrlerin say\u0131s\u0131 s\u00fcrekli artmaktad\u0131r (Kwon et al., 2021). HIFU enerjisi, \u00e7evredeki dokulara zarar vermeden hedef ya\u011f h\u00fccrelerini yok eder. Y\u00fcksek frekanslarda ultrasonlar\u0131n geni\u015f bir \u015fekilde birle\u015fmesi nedeniyle doku y\u0131k\u0131m\u0131 k\u00fc\u00e7\u00fck bir odak noktas\u0131yla s\u0131n\u0131rl\u0131d\u0131r. Ultrason enerjisi, b\u00f6lgede molek\u00fcler titre\u015fimlere neden olarak hedef dokudaki s\u0131cakl\u0131\u011f\u0131 art\u0131r\u0131r ve koag\u00fclasyon yoluyla ya\u011f h\u00fccrelerinin nekrozuna (\u00f6l\u00fcm\u00fcne) sebep olur (Nelson ve ark., 2009; Laubach ve ark.). Bu \u00e7al\u0131\u015fman\u0131n sonu\u00e7lar\u0131, bu \u00fc\u00e7 katmanl\u0131 y\u00f6ntem SMF i\u00e7in ikna edici etkilili\u011fini g\u00f6stermi\u015ftir. Sadece tek bir seans uygulanan tedavi edilen hastalar\u0131n %80’inden fazlas\u0131, klinik uzman\u0131 taraf\u0131ndan bildirilen ve hasta taraf\u0131ndan de\u011ferlendirilen sonu\u00e7lara g\u00f6re iyile\u015fme ve memnuniyet g\u00f6stermi\u015ftir; bu, 3D Vectra sonucunun sonu\u00e7lar\u0131yla tutarl\u0131d\u0131r. G\u00fcvenlik profili, \u00e7o\u011fu hastada yaln\u0131zca hafif ve ge\u00e7ici tedavi sonras\u0131 yan etkiler ve hafif a\u011fr\u0131 oldu\u011funu g\u00f6stermi\u015ftir; bu, HIFU’nun di\u011fer tedavi yakla\u015f\u0131mlar\u0131na k\u0131yasla avantajlar\u0131 olarak beklenen ve yayg\u0131n olarak bilinen bir durumdur (Humphery et al., 2016, Scher et al., 2014). HIFU ile yara izi, kal\u0131c\u0131 uyu\u015fma ve kar\u0131ncalanma hissi, sinir hasar\u0131 gibi ciddi bir komplikasyon g\u00f6zlemlenmedi. Geleneksel y\u00f6ntemlerin s\u0131k\u0131la\u015ft\u0131r\u0131c\u0131 etkilerine ek olarak, bu prosed\u00fcrde MP’li 6.0 mm kartu\u015f, de\u011ferlendirme ve takip temelinde belirgin bir geli\u015fme g\u00f6sterdi. HIFU, ya\u011fl\u0131 dokular\u0131n \u00e7\u0131kar\u0131lmas\u0131 i\u00e7in hassas ve g\u00fcvenli bir yol sa\u011flad\u0131. Emilen ultrason enerjisinden gelen \u0131s\u0131, adipositlerin zar\u0131n\u0131n s\u0131v\u0131la\u015fmas\u0131n\u0131 ve par\u00e7alanmas\u0131n\u0131 tetikler (Ets & Smoller 2011). Mekanik ve termal etkiler birlikte meydana gelebilir ve mekanik aktivite lokal \u0131s\u0131 birikimini art\u0131r\u0131r. Cerrahi olmayan cihazlar\u0131n etkilerini \u00e7o\u011faltabilecek cihazlara y\u00f6nelik \u00e7ok say\u0131da ara\u015ft\u0131rma yap\u0131lm\u0131\u015ft\u0131r (Gadsden et al, 2011). Bu da, non-invaziv prosed\u00fcrlere do\u011fru genel e\u011filime paraleldir. Potansiyel faydalar\u0131na ra\u011fmen, bir\u00e7ok hasta do\u011fas\u0131 gere\u011fi ameliyat tercih etmez. Ya\u011f azaltma ve v\u00fccut \u015fekillendirme i\u00e7in etkili, ancak konforlu ve g\u00fcvenli, minimum iyile\u015fme s\u00fcresine sahip non-invaziv bir y\u00f6ntemi tercih ederler (Coleman et al, 2009). HIFU, ya\u011f azaltma ve y\u00fcz germe i\u00e7in g\u00fcvenli, etkili ve non-invaziv bir se\u00e7enektir. Farkl\u0131 kurumlarda hasta say\u0131s\u0131n\u0131n daha fazla oldu\u011fu \u00e7al\u0131\u015fmalar yap\u0131lmas\u0131 de\u011ferlendirilmelidir. Ayr\u0131ca farkl\u0131 hastalar, farkl\u0131 y\u00f6ntemler, farkl\u0131 \u00e7ekimler ve modlar kullan\u0131larak daha ileri \u00e7al\u0131\u015fmalar yap\u0131lmas\u0131 gerekmektedir.<\/p>\n

Referanslar<\/strong>
\nChoi, S. Y., No, Y. A., Kim, S. Y., Kim, B. J., & Kim, M. N. (2016). Tightening effects of high-intensity focused ultrasound on body skin and subdermal tissue: A pilot study. Journal of the European Academy of Dermatology and Venereology, 30(9), 1599-1602.<\/p>\n

Coleman, K. M., Coleman, W. P., & Benchetrit, A. (2009, December). Non-invasive, external ultrasonic lipolysis. In Seminars in cutaneous medicine and surgery (Vol. 28, No. 4, p. 263)<\/p>\n

ets C, Smoller BR. Evaluation of a novel highintensity focused ultrasound device: preclinical studies in a porcine model. Aesthet Surg J 2011;31:429\u201334.<\/p>\n

Gadsden E, Aguilar MT, Smoller BR, Jewell ML. Evaluation of a novel high-intensity focused ultrasound device for ablating subcutaneous adipose tissue for noninvasive body contouring: safety studies in human volunteers. Aesthet Surg J 2011;31:401\u201310<\/p>\n

Humphrey S, Sykes J, Kantor J, Bertucci V, et al. ATX-101 for reduction of submental fat: a phase III randomized controlled trial. J Am Acad Dermatol 2016;75:788\u201397.<\/p>\n

Kamer, F. M., & Minoli, J. J. (1993). Postoperative Platysmal Band Deformity: A Pitfall of Submental Liposuction. Archives of Otolaryngology\u2013Head & Neck Surgery, 119(2), 193\u2013196. https:\/\/doi.org\/10.1001\/archotol.1993.01880140079013<\/p>\n

Kwon, H. H., Yang, S. H., Choi, M., Jung, J. Y., & Park, G. H. (2021). Tightening and Reduction of Unwanted Submental Fat Using Triple-Layer High-Intensity Focused Ultrasound: Clinical and 3-Dimensional Imaging Analysis. Dermatologic Surgery, 47(12), 1595-1600.<\/p>\n

Laubach HJ, Makin IR, Barthe PG, Slayton MH, et al. Intense focused ultrasound: evaluation of a new treatment modality for precise microcoagulation within the skin. Dermatol Surg 2008;34:727\u201334.<\/p>\n

McDiarmid, J., Ruiz, J. B., Lee, D., Lippert, S., Hartisch, C., & Havlickova, B. (2014). Results from a pooled analysis of two European, randomized, placebo-controlled, phase 3 studies of ATX-101 for the pharmacologic reduction of excess submental fat. Aesthetic Plastic Surgery, 38(5), 849-860.<\/p>\n

Nelson AA, Wasserman D, Avram MM. Cryolipolysis for reduction of excess adipose tissue. Semin Cutan Med Surg 2009;28:244\u20139<\/p>\n

Oni, G., Hoxworth, R., Teotia, S., Brown, S., & Kenkel, J. M. (2014). Evaluation of a micro-focused ultrasound system for improving skin laxity and tightening in the lower face. Aesthetic Surgery Journal, 34(7), 1099-1110.<\/p>\n

Park, H., Kim, E., Kim, J., Ro, Y., & Ko, J. (2015). High-Intensity Focused Ultrasound for the Treatment of Wrinkles and Skin Laxity in Seven Different Facial Areas. Annals of Dermatology, 27(6), 688\u2013693. https:\/\/doi.org\/10.5021\/ad.2015.27.6.688<\/p>\n

scher B, Hoffmann K, Walker P, Lippert S, et al. Efficacy, patientreported outcomes and safety profile of ATX-101 (deoxycholic acid), an injectable drug for the reduction of unwanted submental fat: results from a phase III, randomized, placebo-controlled study. J Eur Acad Dermatol Venereol 2014;28:1707\u201315.<\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Y\u00fcksek Yo\u011funluklu Odaklanm\u0131\u015f Ultrason (HIFU) ile \u0130stenmeyen Submental Ya\u011f\u0131n Azalt\u0131lmas\u0131nda Etki ve G\u00fcvenlik ARKA PLAN: “\u00c7ift \u00e7ene”(g\u0131d\u0131) t\u0131bbi olarak submental ya\u011f, g\u00fcn\u00fcm\u00fcz\u00fcn g\u00fczellik standartlar\u0131nda istenmeyen bir g\u00f6r\u00fcnt\u00fc haline gelmi\u015ftir. Bu durum ya\u015flanma ve obezite g\u00f6r\u00fcn\u00fcm\u00fc verir. Y\u00fcksek yo\u011funluklu odaklanm\u0131\u015f ultrason (HIFU), submental hacmi azaltman\u0131n olduk\u00e7a g\u00fcvenli bir yolu olarak kabul edilmektedir. AMA\u00c7: Bu \u00e7al\u0131\u015fman\u0131n amac\u0131, […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"page-with-left-sidebar","format":"standard","meta":{"saved_in_kubio":false,"footnotes":""},"categories":[11],"tags":[],"class_list":["post-2513","post","type-post","status-publish","format-standard","hentry","category-standard-posts"],"_links":{"self":[{"href":"https:\/\/test.wbx.com.tr\/index.php\/wp-json\/wp\/v2\/posts\/2513","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/test.wbx.com.tr\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/test.wbx.com.tr\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/test.wbx.com.tr\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/test.wbx.com.tr\/index.php\/wp-json\/wp\/v2\/comments?post=2513"}],"version-history":[{"count":43,"href":"https:\/\/test.wbx.com.tr\/index.php\/wp-json\/wp\/v2\/posts\/2513\/revisions"}],"predecessor-version":[{"id":3082,"href":"https:\/\/test.wbx.com.tr\/index.php\/wp-json\/wp\/v2\/posts\/2513\/revisions\/3082"}],"wp:attachment":[{"href":"https:\/\/test.wbx.com.tr\/index.php\/wp-json\/wp\/v2\/media?parent=2513"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/test.wbx.com.tr\/index.php\/wp-json\/wp\/v2\/categories?post=2513"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/test.wbx.com.tr\/index.php\/wp-json\/wp\/v2\/tags?post=2513"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}